Last reviewed · How we verify

Polyherbal capsule coccinia, bougainvillea, catharanthus

Composite Interceptive Med Science · Phase 1 active Small molecule

Polyherbal capsule coccinia, bougainvillea, catharanthus is a Small molecule drug developed by Composite Interceptive Med Science. It is currently in Phase 1 development. Also known as: Sugar Balance (SB).

At a glance

Generic namePolyherbal capsule coccinia, bougainvillea, catharanthus
Also known asSugar Balance (SB)
SponsorComposite Interceptive Med Science
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Polyherbal capsule coccinia, bougainvillea, catharanthus

What is Polyherbal capsule coccinia, bougainvillea, catharanthus?

Polyherbal capsule coccinia, bougainvillea, catharanthus is a Small molecule drug developed by Composite Interceptive Med Science.

Who makes Polyherbal capsule coccinia, bougainvillea, catharanthus?

Polyherbal capsule coccinia, bougainvillea, catharanthus is developed by Composite Interceptive Med Science (see full Composite Interceptive Med Science pipeline at /company/composite-interceptive-med-science).

Is Polyherbal capsule coccinia, bougainvillea, catharanthus also known as anything else?

Polyherbal capsule coccinia, bougainvillea, catharanthus is also known as Sugar Balance (SB).

What development phase is Polyherbal capsule coccinia, bougainvillea, catharanthus in?

Polyherbal capsule coccinia, bougainvillea, catharanthus is in Phase 1.

Related